← FDA DRUG APPROVALS

FDA NDA · NDA019037

IMODIUM

Sponsor: JANSSEN PHARMS

APPLICATION
NDA019037
TYPE
NDA
ORIGINAL APPROVAL
1984-07-31
LATEST ACTION
1987-06-16
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

IMODIUMDiscontinued
LOPERAMIDE HYDROCHLORIDE 1MG/5ML · SOLUTION · ORAL

Approval history

1987-06-16Labeling · Supplement 3 · standardAP
1986-06-02Manufacturing (CMC) · Supplement 2 · standardAP
1985-10-29Labeling · Supplement 1 · standardAP
1984-07-31Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →